Katerina P Shetler, MD
Gastroenterology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shetler’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A87559 · Current
Licensed to practise in California · since 2004 · expires 2027-10-31 · Zaporoz Medical Institute.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$157,667
Medicare paid this office $157,667 for 479 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 159 | $37,133 | $232 |
| Test for tone and sensation of rectum and anus | 41 | $22,248 | $543 |
| Return visit (30+ min) | 123 | $18,955 | $110 |
| Biopsy of large bowel using a flexible endoscope | 197 | $14,868 | $75 |
| Long return visit (40+ min) | 62 | $13,843 | $167 |
See all 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 159 | $37,133 | $232 |
| Test for tone and sensation of rectum and anus | 41 | $22,248 | $543 |
| Return visit (30+ min) | 123 | $18,955 | $110 |
| Biopsy of large bowel using a flexible endoscope | 197 | $14,868 | $75 |
| Long return visit (40+ min) | 62 | $13,843 | $167 |
| Study of rectum sensitivity and function | 41 | $11,984 | $292 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 90 | $8,641 | $92 |
| Study of esophagus to assess movement | 14 | $3,309 | $236 |
| Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | 23 | $3,168 | $138 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 12 | $2,165 | $180 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 24 | $2,026 | $81 |
| Short return visit (20+ min) | 23 | $1,879 | $78 |
| Injection beneath lining of large bowel using a flexible endoscope | 91 | $1,376 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 150 | $623 | $4 |
| Measurement of liver stiffness | 11 | $322 | $29 |
Procedures Medicare counted
| Colonoscopy | 63 | More than 69% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 92 | More than 75% of doctors who do this |
Who their Medicare patients are
479 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 12% · Women 68% · Also on Medicaid 18% · Health risk score 0.90. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 63% · Diabetes 24% · Depression 23% · Coronary heart disease 22% · Chronic kidney disease 16% · Cancer 16% · Atrial fibrillation 14% · Heart failure 8% · COPD 6% · Stroke 4% · Dementia 3%.
The office billed $1,406,425, Medicare allowed $198,387 and paid $157,667; for 1,229 services of 37 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 479 | 1,229 | 74 | 0.90 | $1,406,425 | $157,667 |
| 2023 | 471 | 1,282 | 75 | 0.93 | $1,329,626 | $152,728 |
| 2022 | 473 | 1,282 | 74 | 1.01 | $1,112,086 | $144,869 |
| 2021 | 521 | 1,433 | 74 | 1.00 | $1,105,254 | $147,203 |
| 2020 | 433 | 1,319 | 74 | 1.09 | $1,025,538 | $142,075 |
| 2019 | 482 | 1,356 | 74 | 1.07 | $1,133,696 | $154,701 |
| 2018 | 475 | 1,531 | 73 | 1.17 | $1,143,615 | $145,356 |
| 2017 | 395 | 1,341 | 73 | 1.22 | $921,998 | $118,469 |
| 2016 | 340 | 934 | 73 | 1.12 | $745,026 | $102,228 |
| 2015 | 249 | 721 | 73 | 1.12 | $530,663 | $92,633 |
| 2014 | 205 | 667 | 73 | 1.07 | $449,339 | $68,616 |
| 2013 | 177 | 568 | 69 | 1.71 | $319,401 | $53,829 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 146 | $35,744 | $240 |
| Return visit (30+ min) | 140 | $27,267 | $115 |
| Biopsy of large bowel using a flexible endoscope | 219 | $19,202 | $86 |
| Test for tone and sensation of rectum and anus | 24 | $13,675 | $570 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 100 | $10,117 | $95 |
| Study of rectum sensitivity and function | 24 | $7,121 | $297 |
| Long return visit (40+ min) | 28 | $6,338 | $171 |
| Study of esophagus to assess movement | 16 | $3,856 | $241 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 16 | $2,938 | $184 |
| Short return visit (20+ min) | 26 | $2,423 | $78 |
| New patient visit (45+ min) | 12 | $1,933 | $161 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 19 | $1,792 | $90 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,592 | $100 |
| Injection beneath lining of large bowel using a flexible endoscope | 75 | $1,225 | $16 |
| New patient visit (30+ min) | 15 | $1,038 | $69 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 163 | $773 | $5 |
2022: 21 services
| Return visit (30+ min) | 138 | $27,872 | $116 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 112 | $26,743 | $235 |
| Biopsy of large bowel using a flexible endoscope | 164 | $14,929 | $90 |
| Test for tone and sensation of rectum and anus | 20 | $11,816 | $591 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 98 | $10,014 | $98 |
| Short return visit (20+ min) | 62 | $6,385 | $84 |
| Study of rectum sensitivity and function | 20 | $5,978 | $299 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 53 | $5,436 | $95 |
| Study of esophagus to assess movement | 16 | $3,721 | $233 |
| Long return visit (40+ min) | 22 | $3,683 | $160 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 16 | $2,880 | $180 |
| New patient visit (30+ min) | 30 | $2,876 | $96 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,349 | $214 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,839 | $123 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,768 | $104 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 170 | $866 | $5 |
| Study of esophagus to assess movement | 14 | $799 | $57 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 13 | $605 | $47 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 27 | $591 | $22 |
| Injection beneath lining of large bowel using a flexible endoscope | 38 | $583 | $15 |
| Review by radiologist of placement of long small bowel tube | 12 | $290 | $24 |
2021: 21 services
| Return visit (30+ min) | 157 | $29,987 | $117 |
| Biopsy of large bowel using a flexible endoscope | 168 | $20,144 | $116 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 79 | $18,375 | $227 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 110 | $11,760 | $99 |
| Short return visit (20+ min) | 81 | $9,149 | $86 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 89 | $8,149 | $91 |
| Prolonged monitoring and recording of esophageal function through nasal tube with electrode | 15 | $7,594 | $506 |
| Study of esophagus to assess movement | 23 | $5,532 | $241 |
| Long return visit (40+ min) | 21 | $4,048 | $162 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 18 | $3,432 | $191 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,795 | $93 |
| New patient visit (30+ min) | 25 | $2,457 | $98 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $2,139 | $113 |
| Study of rectum sensitivity and function | 23 | $1,912 | $83 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 50 | $1,169 | $22 |
| Study of esophagus to assess movement | 18 | $1,117 | $62 |
| Test for tone and sensation of rectum and anus | 22 | $1,017 | $46 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 18 | $844 | $47 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 158 | $809 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 46 | $714 | $15 |
| Review by radiologist of placement of long small bowel tube | 17 | $443 | $25 |
2020: 18 services
| Return visit (30+ min) | 144 | $25,947 | $103 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 74 | $17,619 | $235 |
| Test for tone and sensation of rectum and anus | 31 | $16,552 | $534 |
| Biopsy of large bowel using a flexible endoscope | 143 | $15,959 | $109 |
| Short return visit (20+ min) | 98 | $9,760 | $66 |
| Study of rectum sensitivity and function | 31 | $8,292 | $267 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 75 | $7,795 | $96 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 72 | $6,189 | $83 |
| Telephone medical discussion with physician, 11-20 minutes | 34 | $4,155 | $74 |
| Long return visit (40+ min) | 28 | $3,911 | $130 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $2,085 | $130 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $2,001 | $105 |
| Study of esophagus to assess movement | 20 | $1,350 | $64 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,173 | $98 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 20 | $1,019 | $49 |
| Injection beneath lining of large bowel using a flexible endoscope | 62 | $953 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 118 | $626 | $5 |
| Review by radiologist of placement of long small bowel tube | 17 | $442 | $26 |
2019: 17 services
| Return visit (30+ min) | 175 | $31,147 | $96 |
| Test for tone and sensation of rectum and anus | 50 | $24,527 | $491 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 82 | $19,497 | $238 |
| Biopsy of large bowel using a flexible endoscope | 149 | $16,093 | $108 |
| Study of rectum sensitivity and function | 50 | $12,464 | $249 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 89 | $9,519 | $98 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 95 | $7,962 | $77 |
| Short return visit (20+ min) | 88 | $7,254 | $69 |
| Long return visit (40+ min) | 31 | $4,689 | $134 |
| Study of esophagus to assess movement | 19 | $3,719 | $196 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 14 | $2,410 | $172 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $2,066 | $90 |
| Injection beneath lining of large bowel using a flexible endoscope | 79 | $1,210 | $15 |
| Study of esophagus to assess movement | 15 | $934 | $62 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 14 | $662 | $47 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 123 | $621 | $5 |
| Review by radiologist of placement of long small bowel tube | 13 | $325 | $25 |
2018: 20 services
| Return visit (30+ min) | 148 | $23,726 | $93 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 97 | $21,948 | $226 |
| Test for tone and sensation of rectum and anus | 37 | $16,140 | $425 |
| Biopsy of large bowel using a flexible endoscope | 141 | $10,491 | $74 |
| Short return visit (20+ min) | 99 | $8,901 | $64 |
| Study of rectum sensitivity and function | 37 | $8,594 | $226 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 109 | $8,245 | $70 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 77 | $7,600 | $93 |
| Long return visit (40+ min) | 48 | $6,736 | $130 |
| Prolonged monitoring and recording of esophageal function through nasal tube with electrode | 12 | $5,445 | $454 |
| Study of esophagus to assess movement | 23 | $4,015 | $175 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 20 | $3,227 | $161 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,932 | $101 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,752 | $117 |
| Injection beneath lining of large bowel using a flexible endoscope | 95 | $1,419 | $15 |
| Study of esophagus to assess movement | 22 | $1,289 | $59 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 22 | $988 | $45 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 64 | $925 | $11 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 135 | $668 | $5 |
| Review by radiologist of placement of long small bowel tube | 22 | $523 | $24 |
2017: 20 services
| Return visit (30+ min) | 136 | $21,337 | $95 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 75 | $17,191 | $226 |
| Test for tone and sensation of rectum and anus | 26 | $11,278 | $434 |
| Short return visit (20+ min) | 105 | $9,624 | $63 |
| Biopsy of large bowel using a flexible endoscope | 115 | $9,618 | $82 |
| Long return visit (40+ min) | 52 | $6,165 | $116 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | $5,955 | $86 |
| Study of rectum sensitivity and function | 26 | $5,769 | $222 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 54 | $4,381 | $73 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 21 | $2,210 | $100 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,894 | $111 |
| Study of esophagus to assess movement | 11 | $1,773 | $161 |
| Injection beneath lining of large bowel using a flexible endoscope | 76 | $1,633 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 97 | $1,363 | $10 |
| Study of rectum sensitivity and function | 11 | $873 | $79 |
| Study of esophagus to assess movement | 14 | $827 | $59 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 12 | $537 | $45 |
| Test for tone and sensation of rectum and anus | 11 | $483 | $44 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 102 | $422 | $4 |
| Review by radiologist of placement of long small bowel tube | 15 | $379 | $24 |
2016: 19 services
| Return visit (30+ min) | 141 | $26,643 | $93 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 54 | $12,653 | $230 |
| Long return visit (40+ min) | 89 | $11,781 | $121 |
| Biopsy of large bowel using a flexible endoscope | 100 | $10,989 | $108 |
| Test for tone and sensation of rectum and anus | 13 | $5,067 | $390 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 42 | $4,705 | $105 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 35 | $3,073 | $77 |
| Study of rectum sensitivity and function | 13 | $2,874 | $221 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,733 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,953 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,429 | $119 |
| New patient visit (45+ min) | 11 | $1,255 | $114 |
| Study of esophagus to assess movement | 18 | $1,132 | $60 |
| Study of rectum sensitivity and function | 14 | $1,091 | $78 |
| Short return visit (20+ min) | 13 | $874 | $62 |
| Injection beneath lining of large bowel using a flexible endoscope | 44 | $858 | $19 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 13 | $587 | $45 |
| Test for tone and sensation of rectum and anus | 14 | $576 | $41 |
| Review by radiologist of placement of long small bowel tube | 13 | $335 | $24 |
2015: 15 services
| Return visit (30+ min) | 113 | $25,495 | $99 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 33 | $9,517 | $280 |
| Long return visit (40+ min) | 61 | $9,401 | $140 |
| Biopsy of large bowel using a flexible endoscope | 60 | $8,079 | $132 |
| Test for tone and sensation of rectum and anus | 19 | $7,944 | $418 |
| Study of rectum sensitivity and function | 20 | $4,384 | $219 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 30 | $3,278 | $102 |
| Study of esophagus to assess movement | 16 | $2,481 | $155 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 28 | $2,430 | $69 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 15 | $2,195 | $146 |
| New patient visit (45+ min) | 16 | $2,132 | $133 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,648 | $127 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,325 | $102 |
| Study of esophagus to assess movement | 13 | $769 | $59 |
| Injection beneath lining of large bowel using a flexible endoscope | 16 | $455 | $27 |
2014: 16 services
| Return visit (30+ min) | 110 | $19,529 | $90 |
| Long return visit (40+ min) | 37 | $5,493 | $125 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 36 | $3,926 | $101 |
| Biopsy of large bowel using a flexible endoscope | 20 | $3,192 | $145 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $3,166 | $264 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 29 | $3,078 | $83 |
| Study of rectum sensitivity and function | 37 | $2,915 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,678 | $122 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $2,207 | $110 |
| Study of esophagus to assess movement | 12 | $2,112 | $176 |
| New patient visit (30+ min) | 21 | $2,106 | $100 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 11 | $1,783 | $149 |
| Ultrasound exam of lower large bowel using a flexible endoscope | 11 | $1,548 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,473 | $64 |
| Test for tone and sensation of rectum and anus | 29 | $1,323 | $46 |
| Study of esophagus to assess movement | 19 | $1,125 | $59 |
2013: 11 services
| Return visit (30+ min) | 73 | $11,824 | $92 |
| Long return visit (40+ min) | 58 | $9,032 | $110 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 38 | $4,923 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $3,243 | $62 |
| Biopsy of large bowel using a flexible endoscope | 16 | $3,061 | $191 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $2,300 | $121 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,266 | $113 |
| New patient visit (30+ min) | 16 | $1,611 | $101 |
| Study of rectum sensitivity and function | 15 | $1,192 | $79 |
| Study of esophagus to assess movement | 13 | $763 | $59 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 21 | $221 | $10 |
Medicaid work
$143 in 2022
Medicaid paid $143 for 29 billed services this clinician did in 2022, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 29 | $143 |
| 2022 | 29 | 1 | 15 | $143 |
| 2021 | 16 | 1 | 15 | $97 |
| 2020 | 29 | 1 | 15 | $739 |
| 2019 | 41 | 1 | 16 | $1,472 |
See the largest Medicaid services in earlier years
2021
| Return visit (30+ min) | 16 | $97 |
2020
| Return visit (30+ min) | 29 | $739 |
2019
| Return visit (30+ min) | 41 | $1,472 |
Drugs they prescribed that Part D paid
$156,481
Pharmacies billed $156,481 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 882) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
696 generic and 186 brand-name prescriptions · $156,481 in drug cost · 25 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xifaxan | 16 | $41,693 | $2,606 |
| Creon | 22 | $38,562 | $1,753 |
| Linzess | 19 | $28,045 | $1,476 |
| Dexlansoprazole Dr | 22 | $9,552 | $434 |
| Sod Sulf-Potass Sulf-Mag Sulf | 94 | $6,219 | $66 |
See all 15 drugs
| Xifaxan | 16 | $41,693 | $2,606 |
| Creon | 22 | $38,562 | $1,753 |
| Linzess | 19 | $28,045 | $1,476 |
| Dexlansoprazole Dr | 22 | $9,552 | $434 |
| Sod Sulf-Potass Sulf-Mag Sulf | 94 | $6,219 | $66 |
| Peg 3350-Electrolyte | 121 | $2,492 | $21 |
| Pantoprazole | 129 | $2,158 | $17 |
| Famotidine | 85 | $1,731 | $20 |
| Omeprazole | 103 | $1,259 | $12 |
| Cholestyramine | 17 | $997 | $59 |
| Gavilyte-G | 59 | $804 | $14 |
| Gabapentin | 24 | $727 | $30 |
| Dicyclomine | 32 | $597 | $19 |
| Peg-3350 and Electrolytes | 27 | $398 | $15 |
| Gavilyte-C | 23 | $370 | $16 |
Year by year
| 2024 | 882 | 426 | 0% (0) | 21% | $156,481 |
| 2023 | 951 | 379 | 0% (0) | 20% | $203,880 |
| 2022 | 1,117 | 360 | 0% (0) | 27% | $350,946 |
| 2021 | 1,110 | 345 | 0% (0) | 29% | $316,373 |
| 2020 | 952 | 257 | 0% (0) | 26% | $277,431 |
| 2019 | 779 | 241 | 0% (0) | 30% | $210,915 |
| 2018 | 796 | 228 | 0% (0) | 27% | $174,940 |
| 2017 | 691 | 211 | 0% (0) | 32% | $164,147 |
| 2016 | 709 | 209 | 0% (0) | 28% | $139,473 |
| 2015 | 725 | 144 | 0% (0) | None | $99,834 |
| 2014 | 548 | 100 | 0% (0) | 31% | $86,807 |
| 2013 | 477 | 90 | 0% (0) | 35% | $56,156 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Creon | 33 | $71,942 | $2,180 |
| Xifaxan | 15 | $41,762 | $2,784 |
| Linzess | 19 | $32,872 | $1,730 |
| Sod Sulf-Potass Sulf-Mag Sulf | 95 | $7,348 | $77 |
| Famotidine | 102 | $3,556 | $35 |
| Peg 3350-Electrolyte | 146 | $3,321 | $23 |
| Omeprazole | 136 | $2,997 | $22 |
| Pantoprazole | 168 | $2,838 | $17 |
| Sucralfate | 13 | $2,626 | $202 |
| Cholestyramine | 20 | $2,218 | $111 |
| Dicyclomine | 49 | $1,632 | $33 |
| Gabapentin | 34 | $1,580 | $46 |
| Esomeprazole Magnesium | 13 | $483 | $37 |
| Metoclopramide | 16 | $68 | $4 |
2022: 15 drugs
| Xifaxan | 42 | $114,951 | $2,737 |
| Creon | 53 | $98,755 | $1,863 |
| Linzess | 35 | $41,009 | $1,172 |
| Suprep | 61 | $6,966 | $114 |
| Famotidine | 136 | $3,804 | $28 |
| Pantoprazole | 173 | $3,048 | $18 |
| Omeprazole | 141 | $2,513 | $18 |
| Peg 3350-Electrolyte | 104 | $1,966 | $19 |
| Gabapentin | 43 | $1,653 | $38 |
| Sod Sulf-Potass Sulf-Mag Sulf | 19 | $1,542 | $81 |
| Cholestyramine | 14 | $1,425 | $102 |
| Dicyclomine | 54 | $1,380 | $26 |
| Esomeprazole Magnesium | 35 | $1,270 | $36 |
| Metoclopramide | 23 | $80 | $3 |
| Spironolactone | 12 | $64 | $5 |
2021: 18 drugs
| Xifaxan | 33 | $87,372 | $2,648 |
| Creon | 44 | $77,572 | $1,763 |
| Linzess | 62 | $65,323 | $1,054 |
| Dexilant | 25 | $25,312 | $1,012 |
| Suprep | 95 | $10,546 | $111 |
| Famotidine | 138 | $3,244 | $24 |
| Omeprazole | 174 | $2,810 | $16 |
| Pantoprazole | 127 | $2,276 | $18 |
| Esomeprazole Magnesium | 35 | $1,830 | $52 |
| Azithromycin | 13 | $1,256 | $97 |
| Dicyclomine | 58 | $1,201 | $21 |
| Gabapentin | 59 | $1,183 | $20 |
| Cholestyramine | 11 | $1,159 | $105 |
| Peg 3350-Electrolyte | 24 | $345 | $14 |
| Gavilyte-G | 26 | $334 | $13 |
| Peg-3350 and Electrolytes | 25 | $303 | $12 |
| Metronidazole | 14 | $160 | $11 |
| Metoclopramide | 16 | $74 | $5 |
2020: 16 drugs
| Xifaxan | 27 | $78,761 | $2,917 |
| Creon | 40 | $72,364 | $1,809 |
| Linzess | 70 | $56,231 | $803 |
| Suprep | 58 | $6,082 | $105 |
| Famotidine | 105 | $3,064 | $29 |
| Omeprazole | 217 | $2,719 | $13 |
| Azithromycin | 26 | $1,808 | $70 |
| Pantoprazole | 102 | $1,456 | $14 |
| Esomeprazole Magnesium | 11 | $1,195 | $109 |
| Dicyclomine | 48 | $1,011 | $21 |
| Gabapentin | 56 | $636 | $11 |
| Ondansetron Odt | 14 | $575 | $41 |
| Peg 3350-Electrolyte | 17 | $257 | $15 |
| Gavilyte-N | 15 | $216 | $14 |
| Gavilyte-C | 14 | $204 | $15 |
| Gavilyte-G | 12 | $148 | $12 |
2019: 14 drugs
| Creon | 34 | $59,506 | $1,750 |
| Linzess | 57 | $50,871 | $892 |
| Xifaxan | 27 | $46,588 | $1,725 |
| Dexilant | 16 | $19,642 | $1,228 |
| Suprep | 47 | $4,699 | $100 |
| Omeprazole | 157 | $2,333 | $15 |
| Famotidine | 99 | $1,751 | $18 |
| Gabapentin | 33 | $600 | $18 |
| Dicyclomine | 30 | $516 | $17 |
| Pantoprazole | 60 | $500 | $8 |
| Ranitidine | 22 | $376 | $17 |
| Gavilyte-C | 23 | $256 | $11 |
| Ondansetron Odt | 13 | $192 | $15 |
| Gavilyte-G | 12 | $99 | $8 |
2018: 20 drugs
| Xifaxan | 29 | $53,017 | $1,828 |
| Linzess | 58 | $41,008 | $707 |
| Creon | 14 | $19,465 | $1,390 |
| Zenpep | 13 | $7,905 | $608 |
| Suprep | 53 | $4,901 | $92 |
| Omeprazole | 156 | $2,195 | $14 |
| Cholestyramine | 16 | $1,975 | $123 |
| Famotidine | 76 | $1,146 | $15 |
| Azithromycin | 12 | $1,061 | $88 |
| Gabapentin | 21 | $609 | $29 |
| Polyethylene Glycol 3350 | 29 | $553 | $19 |
| Peg 3350-Electrolyte | 29 | $507 | $17 |
| Dicyclomine | 40 | $487 | $12 |
| Proctozone-Hc | 11 | $434 | $39 |
| Pantoprazole | 48 | $351 | $7 |
| Lansoprazole | 15 | $341 | $23 |
| Ranitidine | 24 | $339 | $14 |
| Gavilyte-N | 15 | $263 | $18 |
| Gavilyte-G | 22 | $262 | $12 |
| Nortriptyline | 17 | $155 | $9 |
2017: 15 drugs
| Xifaxan | 38 | $56,312 | $1,482 |
| Linzess | 56 | $33,352 | $596 |
| Creon | 20 | $30,150 | $1,508 |
| Suprep | 24 | $2,136 | $89 |
| Omeprazole | 136 | $1,947 | $14 |
| Azithromycin | 12 | $975 | $81 |
| Famotidine | 49 | $636 | $13 |
| Peg 3350-Electrolyte | 47 | $635 | $14 |
| Polyethylene Glycol 3350 | 31 | $588 | $19 |
| Lansoprazole | 19 | $468 | $25 |
| Pantoprazole | 46 | $409 | $9 |
| Gavilyte-N | 19 | $296 | $16 |
| Gabapentin | 27 | $228 | $8 |
| Dicyclomine | 23 | $155 | $7 |
| Nortriptyline | 16 | $121 | $8 |
2016: 17 drugs
| Creon | 24 | $32,911 | $1,371 |
| Xifaxan | 23 | $30,322 | $1,318 |
| Aciphex | 12 | $23,205 | $1,934 |
| Linzess | 35 | $19,319 | $552 |
| Omeprazole | 150 | $2,287 | $15 |
| Carafate | 11 | $1,733 | $158 |
| Azithromycin | 11 | $931 | $85 |
| Pantoprazole | 51 | $837 | $16 |
| Peg 3350-Electrolyte | 48 | $745 | $16 |
| Famotidine | 51 | $517 | $10 |
| Gavilyte-N | 27 | $461 | $17 |
| Polyethylene Glycol 3350 | 21 | $407 | $19 |
| Gabapentin | 33 | $350 | $11 |
| Nortriptyline | 20 | $315 | $16 |
| Ranitidine | 20 | $234 | $12 |
| Lansoprazole | 12 | $224 | $19 |
| Dicyclomine | 16 | $140 | $9 |
2015: 16 drugs
| Xifaxan | 26 | $30,335 | $1,167 |
| Creon | 13 | $16,358 | $1,258 |
| Linzess | 28 | $15,156 | $541 |
| Carafate | 17 | $3,264 | $192 |
| Omeprazole | 153 | $2,287 | $15 |
| Moviprep | 12 | $960 | $80 |
| Famotidine | 72 | $821 | $11 |
| Pantoprazole | 37 | $645 | $17 |
| Polyethylene Glycol 3350 | 17 | $449 | $26 |
| Azithromycin | 22 | $371 | $17 |
| Peg 3350-Electrolyte | 20 | $338 | $17 |
| Gabapentin | 34 | $317 | $9 |
| Diltiazem | 13 | $257 | $20 |
| Gavilyte-N | 11 | $224 | $20 |
| Dicyclomine | 30 | $181 | $6 |
| Ranitidine | 25 | $173 | $7 |
2014: 12 drugs
| Creon | 22 | $36,113 | $1,642 |
| Xifaxan | 11 | $11,354 | $1,032 |
| Linzess | 26 | $9,839 | $378 |
| Carafate | 32 | $4,456 | $139 |
| Omeprazole | 129 | $2,754 | $21 |
| Moviprep | 14 | $1,352 | $97 |
| Pantoprazole | 38 | $735 | $19 |
| Famotidine | 41 | $515 | $13 |
| Gabapentin | 17 | $138 | $8 |
| Atenolol | 12 | $86 | $7 |
| Lisinopril | 12 | $86 | $7 |
| Ranitidine | 13 | $42 | $3 |
2013: 14 drugs
| Nexium | 27 | $9,142 | $339 |
| Carafate | 30 | $5,376 | $179 |
| Dexilant | 21 | $4,218 | $201 |
| Amitiza | 11 | $2,858 | $260 |
| Omeprazole | 70 | $1,763 | $25 |
| Moviprep | 13 | $948 | $73 |
| Polyethylene Glycol 3350 | 12 | $582 | $49 |
| Nortriptyline | 43 | $338 | $8 |
| Famotidine | 27 | $261 | $10 |
| Pantoprazole | 13 | $219 | $17 |
| Sertraline | 11 | $99 | $9 |
| Atenolol | 11 | $79 | $7 |
| Lisinopril | 11 | $79 | $7 |
| Simvastatin | 11 | $79 | $7 |
Money from drug and device companies
$76 in 2025
| 2025 | 1 | 1 | None | $76 |
| 2024 | 1 | 1 | None | $12 |
| 2019 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | None | $76 | 1 payment
|
See the published payment
| Gilead Sciences | Meals · 2025-05-01 | None | $76 |
See earlier years (2024, 2019)
2024: $12
| Micro-tech Endoscopy USA | Eyemx | $12 | 1 payment
|
2019: $20
| Amgen | None | $20 | 1 payment
|
Professional record
- NPI
- 1699972927
- Licence
- CA A87559California A87559: Current · expires 2027-10-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-06-29
- NPI last updated
- 2013-05-24
This is when the NPI record was last certified, not a medical board exam.